UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 2
February-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2502120


Registration ID:
554188

Page Number

b156-b165

Share This Article


Jetir RMS

Title

VACCINE SAFETY SURVEILLANCE IN PHARMACOVIGILANCE - A REVIEW

Abstract

Abstract: Vaccines play a critical role in mitigating the impact of infectious disease outbreaks, including COVID-19 and monkeypox, representing a landmark achievement in global scientific collaboration and rapid development. For both diseases, vaccines have undergone accelerated regulatory review processes by national regulatory authorities to facilitate timely approval and deployment. Equitable distribution of these vaccines remains a global priority, ensuring access across diverse populations. Simultaneously, robust safety surveillance systems must be urgently established within countries to comprehensively monitor vaccine safety. Such systems are essential for identifying and investigating adverse events of special interest (AESIs) and adverse events following immunization (AEFIs), enabling the assessment of any potential changes in the benefit-risk profiles of the vaccines for both COVID-19 and monkeypox. Additionally, these systems should anticipate and differentiate coincidental events that may be mistakenly linked to vaccination. Effective safety monitoring is vital to maintain public trust, inform regulatory decisions, and ensure the sustained success of global vaccination efforts against both pandemics and emerging threats such as monkeypox. IndexTerms - Adverse Events of Special Interest, Adverse Events Following Immunization, COVID-19, Monkeypox

Key Words

Adverse Events of Special Interest, Adverse Events Following Immunization, COVID-19, Monkeypox ________________

Cite This Article

"VACCINE SAFETY SURVEILLANCE IN PHARMACOVIGILANCE - A REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 2, page no.b156-b165, February-2025, Available :http://www.jetir.org/papers/JETIR2502120.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"VACCINE SAFETY SURVEILLANCE IN PHARMACOVIGILANCE - A REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 2, page no. ppb156-b165, February-2025, Available at : http://www.jetir.org/papers/JETIR2502120.pdf

Publication Details

Published Paper ID: JETIR2502120
Registration ID: 554188
Published In: Volume 12 | Issue 2 | Year February-2025
DOI (Digital Object Identifier):
Page No: b156-b165
Country: Wardha, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000293

Print This Page

Current Call For Paper

Jetir RMS